Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292547532> ?p ?o ?g. }
- W4292547532 endingPage "4039" @default.
- W4292547532 startingPage "4039" @default.
- W4292547532 abstract "Due to its overexpression on the surface of prostate cancer cells, prostate-specific membrane antigen (PSMA) is a relatively novel effective target for molecular imaging and radioligand therapy (RLT) in prostate cancer. Recent studies reported that PSMA is expressed in the neovasculature of various types of cancer and regulates tumour cell invasion as well as tumour angiogenesis. Several authors explored the role of diagnostic and therapeutic PSMA radioligands in various malignancies. In this narrative review, we describe the current status of the literature on PSMA radioligands' application in solid tumours other than prostate cancer to explore their potential role as diagnostic or therapeutic agents, with particular regard to the relevance of PSMA radioligand uptake as neoangiogenetic biomarker. Hence, a comprehensive review of the literature was performed to find relevant articles on the applications of PSMA radioligands in non-prostate solid tumours. Data on the general, methodological and clinical aspects of all included studies were collected. Forty full-text papers were selected for final review, 8 of which explored PSMA radioligand PET/CT performances in gliomas, 3 in salivary gland malignancies, 6 in thyroid cancer, 2 in breast cancer, 16 in renal cell carcinoma and 5 in hepatocellular carcinoma. In the included studies, PSMA radioligand PET showed promising performance in patients with non-prostate solid tumours. Further studies are needed to better define its potential role in oncological patients management, especially in those undergoing antineoangiogenic therapies, and to assess the efficacy of PSMA-RLT in this clinical context." @default.
- W4292547532 created "2022-08-22" @default.
- W4292547532 creator A5006232279 @default.
- W4292547532 creator A5039399374 @default.
- W4292547532 creator A5045560888 @default.
- W4292547532 creator A5046155896 @default.
- W4292547532 creator A5046578756 @default.
- W4292547532 creator A5056963735 @default.
- W4292547532 creator A5057665713 @default.
- W4292547532 creator A5060062899 @default.
- W4292547532 creator A5089691953 @default.
- W4292547532 date "2022-08-21" @default.
- W4292547532 modified "2023-10-05" @default.
- W4292547532 title "PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?" @default.
- W4292547532 cites W1495043122 @default.
- W4292547532 cites W1523804735 @default.
- W4292547532 cites W1607400179 @default.
- W4292547532 cites W1906583407 @default.
- W4292547532 cites W1964785067 @default.
- W4292547532 cites W1967792499 @default.
- W4292547532 cites W1970494047 @default.
- W4292547532 cites W1973942000 @default.
- W4292547532 cites W1978139448 @default.
- W4292547532 cites W1987790899 @default.
- W4292547532 cites W2005814589 @default.
- W4292547532 cites W2009378591 @default.
- W4292547532 cites W2012910968 @default.
- W4292547532 cites W2022540958 @default.
- W4292547532 cites W2032995169 @default.
- W4292547532 cites W2033819744 @default.
- W4292547532 cites W2044702943 @default.
- W4292547532 cites W2049944366 @default.
- W4292547532 cites W2068058103 @default.
- W4292547532 cites W2097255042 @default.
- W4292547532 cites W2105923744 @default.
- W4292547532 cites W2116511683 @default.
- W4292547532 cites W2117384870 @default.
- W4292547532 cites W2120873855 @default.
- W4292547532 cites W2125363072 @default.
- W4292547532 cites W2143030220 @default.
- W4292547532 cites W2145150141 @default.
- W4292547532 cites W2145665617 @default.
- W4292547532 cites W2155644884 @default.
- W4292547532 cites W2259802687 @default.
- W4292547532 cites W2303295229 @default.
- W4292547532 cites W2326988718 @default.
- W4292547532 cites W2400935268 @default.
- W4292547532 cites W2466422293 @default.
- W4292547532 cites W2467018059 @default.
- W4292547532 cites W2537185990 @default.
- W4292547532 cites W2541665535 @default.
- W4292547532 cites W2549823111 @default.
- W4292547532 cites W2552277185 @default.
- W4292547532 cites W2554535346 @default.
- W4292547532 cites W2556290530 @default.
- W4292547532 cites W2560406314 @default.
- W4292547532 cites W2577862693 @default.
- W4292547532 cites W2580660759 @default.
- W4292547532 cites W2606187374 @default.
- W4292547532 cites W2622192984 @default.
- W4292547532 cites W2719499442 @default.
- W4292547532 cites W2749066826 @default.
- W4292547532 cites W2776187196 @default.
- W4292547532 cites W2789201741 @default.
- W4292547532 cites W2791362306 @default.
- W4292547532 cites W2804543691 @default.
- W4292547532 cites W2805198925 @default.
- W4292547532 cites W2809719608 @default.
- W4292547532 cites W2884337913 @default.
- W4292547532 cites W2890995745 @default.
- W4292547532 cites W2892325025 @default.
- W4292547532 cites W2898314774 @default.
- W4292547532 cites W2898689981 @default.
- W4292547532 cites W2912727656 @default.
- W4292547532 cites W2913437988 @default.
- W4292547532 cites W2914618337 @default.
- W4292547532 cites W2922647811 @default.
- W4292547532 cites W2942632852 @default.
- W4292547532 cites W2945663590 @default.
- W4292547532 cites W2947694756 @default.
- W4292547532 cites W2964156099 @default.
- W4292547532 cites W2965988219 @default.
- W4292547532 cites W2973697549 @default.
- W4292547532 cites W2980584272 @default.
- W4292547532 cites W2982320676 @default.
- W4292547532 cites W3001834400 @default.
- W4292547532 cites W3003270145 @default.
- W4292547532 cites W3012329699 @default.
- W4292547532 cites W3038865995 @default.
- W4292547532 cites W3043823419 @default.
- W4292547532 cites W3045928176 @default.
- W4292547532 cites W3083501248 @default.
- W4292547532 cites W3087124297 @default.
- W4292547532 cites W3091971753 @default.
- W4292547532 cites W3093587770 @default.
- W4292547532 cites W3093700105 @default.
- W4292547532 cites W3110787789 @default.
- W4292547532 cites W3115396992 @default.